Blog - Page 3147 of 5752

TuesdayFeb 12, 2013 7:41 am

Cardium Therapeutics, Inc. (CXM) Wound Care Product Awarded Seal of Approval by American Podiatric Medical Association

Today before the opening bell, Cardium Therapeutics announced that the American Podiatric Medical Association (APMA) has granted its prestigious Seal of Approval to Excellagen®, Cardium’s advanced, FDA-cleared wound care product, for improving foot health and mobility. Excellagen is a syringe-based, professional-use, pharmaceutically formulated 2.6% fibrillar Type I bovine collagen gel that functions to activate the wound healing process and accelerate the growth of granulation tissue. Excellagen can be used to treat neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical wounds, and other dermal wounds. APMA, the nation’s leading professional organization for podiatrists, has 53 state component locations across…

MondayFeb 11, 2013 2:42 pm

Quest Rare Minerals Ltd. (QRM) Updates Markets on Pre-Feasibility Study, Prep Work at High-Density Heavy Rare Earth Deposit

Quest Rare Minerals, which was named Prospector of the Year in 2010 by the Quebec Mineral Exploration Association for the importance of the heavy rare earth element deposit discovered by the company at their Strange Lake property (some 133.4k acres), updated markets today regarding the pre-feasibility study being hammered out for the B-Zone deposit at Strange Lake, as well as other developmental progress associated with this exceptional mineralization. Not only is this project an extremely large, highly-concentrated rare earth site, it has key by-products, like niobium and zirconium, in abundance as well. Overall site design projections call for an easily…

MondayFeb 11, 2013 2:42 pm

Advanced Cell Technology, Inc. (ACTC) Clinical Partner Gets FDA Approval to Commence Phase I/II Myopia Study

2013 Advanced Cell Technology’s clinical partner, the University of California, Los Angeles (UCLA), has received FDA approval of its Investigator Investigational New Drug (IND) application, providing a green light for UCLA scientists to commence a phase I/II study using ACT’s retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat myopic macular degeneration (myopia), or nearsightedness. Steven Schwartz, M.D., Ahmanson Professor of Ophthalmology at the David Geffen School of Medicine at UCLA and retina division chief at UCLA’s Jules Stein Eye Institute, will initiate the 12-patient study to evaluate the safety in patients with severe myopia,…

MondayFeb 11, 2013 2:41 pm

How Viscount Systems Inc. (VSYS) is Securing the Market

There are several key market factors that offer support to the future growth of Viscount Systems, provider of advanced security systems for companies, schools, prisons, hospitals, and multi-family high-rises since 1969. • The security industry is under technological pressure to change, pressures brought on by cost requirements, new information security regulations, legacy systems that badly need updating, and powerful new technologies involving communications and networking. • Existing security systems, based upon aging control panel technology, will become increasingly difficult to upgrade, providing an opportunity for the very few full system providers familiar with IT, cloud, and other options, such as…

MondayFeb 11, 2013 11:24 am

VIASPACE, Inc. (VSPC) Ships 25 Acres of Giant King Grass to St. Croix

Today before the opening bell, VIASPACE announced that it has harvested a large number of seedlings from its Giant King Grass nursery in California and had them transported in a 40-foot refrigerated container to St. Croix, US Virgin Islands where they have been planted in a 25-acre propagation nursery operated by Tibbar Energy. Tibbar plans to propagate the Giant King Grass to create a 1,000+ acre plantation to fuel the 7 MW anaerobic digestion power plant under construction. According to today’s press release, the Giant King Grass will be ready to propagate within six months. Tibbar anticipates having the power…

MondayFeb 11, 2013 11:24 am

XSUNX Inc. (XSNX) Video Chart for Monday, February 11, 2013

XSNX is making a double bottom pattern with pretty solid support established at 1 cent. Volume increased on Friday as the stock price rose 12 percent, putting the chart on watch to possibly challenge the resistance at 1.9 cents. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

MondayFeb 11, 2013 11:23 am

Consorteum Holdings, Inc. (CSRH) Secures $30 Million Funding Commitment from AIC Group Holdings

Consorteum Holdings just announced that it has signed a binding term sheet with AIC Group Holdings Limited for a $30,000,000 funding commitment. A private equity group, AIC Group Holdings Limited is a corporation organized under the laws of the British Virgin Islands. The funding procured from this agreement will provide working capital and allow the company to identify potential merger and acquisitions that will strengthen its ability to compete in the online and mobile gaming market place. Consorteum will focus on its new partnership with Knockout Gaming Inc., an Isle of Man Limited corporation, which has a full online casino…

MondayFeb 11, 2013 11:23 am

International Stem Cell Corp. (ISCO) Subsidiary Endorsed by Screen Star Mariel Hemingway

The jump in exposure being given by print and online media to ISCO subsidiary Lifeline Skin Care is highlighted with the recent endorsement by celebrity Mariel Hemingway. The popular screen star has begun promoting Lifeline’s Eye Firming Complex on social shopping network OpenSky.com. There is no marketing influence greater than the recommendation of a friend, relative, or respected acquaintance, and OpenSky taps that power. OpenSky is a platform that connects unique product creators (suppliers) with the world’s most influential content creators (sellers), resulting in shoppers getting to buy goods from the people they know and trust. Here is a peak…

MondayFeb 11, 2013 7:56 am

Duma Energy Corp. (DUMA) Set to Pop on Rising Oil Price with Aggressive, Risk-Adjusted Production and Shrewd Share Structure

Duma Energy is a remarkable domestic oil and gas developer doing work both on and offshore at their actively producing/revenue generating assets in Illinois and Texas, which has also managed to secure a 39% WI in a sizeable, 5.3M-acre onshore petroleum concession in Namibia. An exceptionally tight share structure consisting of 13.2M outstanding and another 4.8M in options and warrants, with a full 8.3M held by the CEO and other company insiders, makes DUMA some tasty low-hanging fruit by investment standards. Moreover, in excess of 75% of capital investment thus far has derived exclusively from the CEO and large insider…

MondayFeb 11, 2013 7:39 am

Rainbow Coral Corp. (RBCC) Leverages Innovation to Meet Demand

Rainbow Coral, via wholly owned subsidiary Rainbow Biosciences, continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. The company specifically pursues opportunities that offer short-term marketability and commercialization potential in key areas like Alzheimer’s, Parkinson’s, and Cancer. Bioscience technology is a growing, dynamic field of innovation that applies life processes to practical uses, such as the manufacturing of medical devices and the development of new bioscience procedures. From pharmaceuticals to pacemakers, genetically engineered plants to gene therapy, bioscience technology can be found virtually anywhere. The pending joint venture with Amarantus BioScience to develop…

Site Search

Company Search